|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2008-02-25 Option Award |
2008-02-26 5:03 pm | N/A 2018-02-25 |
EPIX Pharmaceuticals, Inc. | EPIX | UPRICHARD ANDREW C G (President) | 81,333 | $3.15 | 81,333 (Direct) | View |
| 2008-02-25 Option Award |
2008-02-26 5:03 pm | N/A N/A |
EPIX Pharmaceuticals, Inc. | EPIX | UPRICHARD ANDREW C G (President) | 32,333 | $0 | 32,333 (Direct) |
View |
| 2007-02-05 Option Award |
2007-02-07 9:18 pm |
N/A 2017-02-05 | EPIX Pharmaceuticals, Inc. | EPIX | UPRICHARD ANDREW C G (President) | 56,250 | $6.5 | 56,250 (Direct) |
View |
| 2007-02-05 Option Award |
2007-02-07 9:18 pm | N/A 2017-02-05 |
EPIX Pharmaceuticals, Inc. | EPIX | UPRICHARD ANDREW C G (President) | 3,750 | $6.5 | 3,750 (Direct) |
View |
| 2006-08-18 Option Award | 2006-08-21 4:04 pm |
N/A 2016-08-18 | EPIX Pharmaceuticals, Inc. | EPIX | UPRICHARD ANDREW C G (President) | 150,000 | $7.2 | 150,000 (Direct) | View |
| 2005-03-17 Option Award | 2005-03-21 8:08 pm | N/A 2015-03-17 | EPIX Pharmaceuticals, Inc. | EPIX | UPRICHARD ANDREW C G (President & COO) | 52,500 | $7.15 | 52,500 (Direct) |
View |
| 2004-07-16 Option Award |
2004-07-20 6:05 pm | N/A 2014-07-16 |
EPIX MEDICAL INC | EPIX | UPRICHARD ANDREW C G (President & COO) | 175,000 | $20.38 | 175,000 (Direct) | View |
|
© 2005-2010 SecForm4.Com All rights reserved. Archives: 2010 2009 2008 2007 2006 2005 ... Sat, 20 Mar 2010 20:49:43 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |